Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

John Lewis

Advertisement

John Lewis, PhD, is CEO of Entos Pharmaceuticals.

Articles by John Lewis

scientist holding medical testing tubes or vials of medical pharmaceutical research with blood cells and virus cure using DNA genome sequencing biotechnology as wide banner hologram | Image Credit: © sizsus - © sizsus - stock.adobe.com

Risks and Rewards of Investing in RNA-based Genetic Medicine Manufacturing

ByJohn Lewis
December 2nd 2023

Collaboration is a key component to achieving long-term success with genetic medicines.

Advertisement

Latest Updated Articles

  • scientist holding medical testing tubes or vials of medical pharmaceutical research with blood cells and virus cure using DNA genome sequencing biotechnology as wide banner hologram | Image Credit: © sizsus - © sizsus - stock.adobe.com
    Risks and Rewards of Investing in RNA-based Genetic Medicine Manufacturing

    December 2nd 2023



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

FDA Updates Master Protocol: What Developers Need to Know

2

Pharma Fundamentals: Hold Times in Biopharmaceuticals

3

IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires

4

Merck KGaA Launches Saturnus Bio; Announces Awards

5

Orally Dissolving Films: A Modern Solution for Convenient Drug Delivery

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us